论文部分内容阅读
目的:研究米司非酮联合米索前列醇用于瘢痕子宫中期妊娠引产的治疗效果。方法:选取我院在2013年5月~9月收治的瘢痕子宫中期妊娠引产患者90例,随机分为实验组45例和对照组45例,对照组采用利凡诺针羊膜腔内注射治疗,实验组采用米非司酮联合米索前列醇进行治疗,观察两组患者的宫缩至胎盘娩出的时间及残留物的残留、子宫出血量。结果:实验组患者的宫缩到胎儿娩出的时间短,子宫内残留少,患者产后的子宫出血量也明显减少,治疗效果明显好于对照组。结论:米非司酮联合米索前列醇治疗瘢痕子宫中期妊娠引产具有显著的治疗效果,可以进行临床治疗的应用和推广。
Objective: To study the therapeutic effect of mifepristone combined with misoprostol for induction of labor induced by scar pregnancy. Methods: 90 cases of induced abortion in uterus with uterine scar from May 2013 to September 2013 in our hospital were randomly divided into experimental group (45 cases) and control group (45 cases). The control group received rivanol injection of amniotic membrane, The experimental group was treated with mifepristone combined with misoprostol. The contractions of the contractions and residuals of the placenta and uterine bleeding were observed in two groups. Results: The experimental group of patients with contractions to the fetus delivered a short time, less residual uterus, postpartum patients with uterine bleeding was significantly reduced, the treatment effect was significantly better than the control group. Conclusion: Mifepristone combined with misoprostol in the treatment of induced uterine scar pregnancy has a significant therapeutic effect, which can be used for clinical treatment and promotion.